Skip to main content

. 1973 Jan 6;1(5844):27–28. doi: 10.1136/bmj.1.5844.27

Stilboestrol diphosphate in hypercalcaemia due to parathyroid carcinoma.

G Sigurdsson, N J Woodhouse, S Taylor, G F Joplin

PMCID: PMC1588525 PMID: 4683634

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Gallagher J. C., Nordin B. E. Treatment with with oestrogens of primary hyperparathyroidism in post-menopausal women. Lancet. 1972 Mar 4;1(7749):503–507. doi: 10.1016/s0140-6736(72)90173-0. [DOI] [PubMed] [Google Scholar]
Goepfert H., Smart C. R., Rochlin D. B. Metastatic parathyroid carcinoma and hormonal chemotherapy. Case report and response to hexestrol. Ann Surg. 1966 Nov;164(5):917–920. doi: 10.1097/00000658-196611000-00021. [DOI] [PMC free article] [PubMed] [Google Scholar]
NORDIN B. E., FRASER R. Assessment of urinary phosphate excretion. Lancet. 1960 Apr 30;1(7131):947–951. doi: 10.1016/s0140-6736(60)90836-9. [DOI] [PubMed] [Google Scholar]
O'Riordan J. L., Watson L., Woodhead J. S. Secretion of parathyroid hormone in primary hyperparathyroidism. Clin Endocrinol (Oxf) 1972 Apr;1(2):149–155. doi: 10.1111/j.1365-2265.1972.tb00386.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES